Primary vs. Secondary Anastomosis for Hinchey Stage III-IV Diverticulitis a Prospective Randomized Trial

Primary vs. Secondary Anastomosis After Sigmoid Colon Resection for Perforated Diverticulitis (Hinchey Stage III and IV): a Prospective Multicentric Randomized Trial

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00692393

Acronym

DIVERTI

Enrollment

102

Registered

2008-06-06

Start date

2008-06-01

Completion date

2013-11-01

Last updated

2026-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peritonitis

Brief summary

This study compares primary resection with anastomosis and Hartmann's procedure in an adult population with acute perforated colonic diverticulitis (Hinchey Stage III and IV) METHODS: The primary end point was postoperative mortality. Secondary end points included surgical and medical morbidity, operative time, and length of postoperative hospitalization.

Detailed description

inclusion criteria: hinchey III and IV diverticulitis

Interventions

PROCEDUREHartmann intervention

sigmoid resection, peritoneal and rectal lavage, terminal stoma

PROCEDUREProtected anastomosis resection

sigmoid resection , peritoneal and rectal lavage, anastomosis, diverting stoma

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient with peritonitis du to sigmoid diverticulum complication * Surgeon - anesthetist confirming the 2 surgeries can be performed

Exclusion criteria

* Physical state which can not permit patient to participate * contraindication to surgery * non-diverticulum peritonitis

Design outcomes

Primary

Measure	Time frame
Death rate comparison between two chirurgical strategies	18 months

Countries

France

Contacts

PRINCIPAL_INVESTIGATORJJ TUECH, PhD

UH Rouen

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 17, 2026